Compare IZM & NXTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IZM | NXTS |
|---|---|---|
| Founded | 2011 | 2009 |
| Country | China | Israel |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Video Chains | Agricultural Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5M | 5.3M |
| IPO Year | 2021 | 2021 |
| Metric | IZM | NXTS |
|---|---|---|
| Price | $0.26 | $1.87 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 211.9K | 61.9K |
| Earning Date | 10-24-2025 | 05-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $263,445.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $10.39 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.24 | $0.55 |
| 52 Week High | $2.73 | $23.80 |
| Indicator | IZM | NXTS |
|---|---|---|
| Relative Strength Index (RSI) | 43.39 | 39.05 |
| Support Level | $0.24 | $1.43 |
| Resistance Level | $0.30 | $2.16 |
| Average True Range (ATR) | 0.03 | 0.21 |
| MACD | 0.00 | 0.12 |
| Stochastic Oscillator | 38.27 | 56.16 |
ICZOOM Group Inc. operates an e-commerce platform selling electronic components to SMEs in China across consumer electronics, IoT, automotive, and industrial control sectors. It offers two main product categories: semiconductor products, including integrated circuits and optoelectronics, and electronic equipment and tools such as electromechanical and MRO supplies. The company also provides services like customs clearance, temporary warehousing, and logistics, earning additional commission fees. The majority of its revenue comes from electronic component sales.
Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.